Trials / Completed
CompletedNCT04372888
Examining Choice Architecture for Genetic Testing Decisions
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 1,012 (actual)
- Sponsor
- Boston College · Academic / Other
- Sex
- All
- Age
- 18 Years – 64 Years
- Healthy volunteers
- Accepted
Summary
The goal of this application is to gain a deeper understanding of decision-making for genetic testing and identify effective choice-architecture-based strategies to improve decisions in genetic testing. The investigators hypothesize that choice architecture (i.e. framing) affects decision-making for hypothetical genetic testing scenarios.
Detailed description
After providing opt-in electronic consent, eligible consented participants will be randomized to one of two hypothetical genetic testing scenarios (rare, life-altering genetic condition or common, life-threatening genetic condition). The genetic testing scenarios include brief detailed information about genetic testing (i.e. how results may influence treatment decisions) as well as information about standard approaches to treatment. Subjects will be randomized to receive a framing conditions (e.g. choice, opt-in, opt-out, enhanced choice). Participants will select a preferred testing option to the hypothetical scenario and will complete several validated instruments.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | choice decision frame | active choice for genetic testing |
| BEHAVIORAL | opt-in decision frame | "gain" frame for genetic testing |
| BEHAVIORAL | opt-out decision frame | "loss" frame for genetic testing |
| BEHAVIORAL | enhanced choice (context) decision frame | consequences of genetic testing |
| BEHAVIORAL | enhanced choice (norms) decision frame | social norms for genetic testing |
| BEHAVIORAL | enhanced choice (affect) decision frame | commitments for genetic testing |
Timeline
- Start date
- 2020-03-11
- Primary completion
- 2020-03-26
- Completion
- 2020-03-30
- First posted
- 2020-05-04
- Last updated
- 2024-08-06
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT04372888. Inclusion in this directory is not an endorsement.